Archived App (Last seen on 1 Jun 2026)
This is an archived listing of the app previously available on the App Store.Although the app is no longer distributed by Apple, you can still view its description, screenshots, version history, ratings, and metadata for reference.
About
This app supports the management of ALK-rearranged Non-Small Cell Lung Cancer by providing scientific content and a discussion forum for doctors and patients. It facilitates treatment reminders, adverse event reporting, and access to treatment algorithms.
What's New in Re
1.1.1
January 27, 2023
Bug fixes
Developer apps
FAQ
What is Re-ALK used for?
Re-ALK is designed to improve the management of ALK-rearranged Non-Small Cell Lung Cancer. It provides scientific content, a discussion forum, treatment reminders, and adverse event reporting for both doctors and patients.
Is Re-ALK free to use?
Yes, Re-ALK is available for free. It does not have any associated costs for download or use.
Does Re-ALK have ads?
No, Re-ALK does not contain advertisements. Users can access its features without interruption from ads.
What devices does Re-ALK support?
Re-ALK is currently supported on iPhone and iPod devices.
How often is Re-ALK updated?
Re-ALK was last updated on January 27, 2023, with version 1.1.1. The release date was January 26, 2023.
What is the age rating for Re-ALK?
Re-ALK has an age rating of 17+, indicating it is intended for mature audiences.
Can patients report adverse events with Re-ALK?
Yes, patients can use Re-ALK to set reminders for their treatment and report adverse events on a regular basis. Doctors can then receive and track these reports.
What kind of content does Re-ALK offer for doctors?
For doctors, Re-ALK offers scientific content related to ALK-rearranged Non-Small Cell Lung Cancer and access to decisional algorithms for different treatment lines.
